BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Business

  Henry Schein Reports Solid First-Quarter 2024 Financial Results and Updates 2024 Financial Guidance

  Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, reported financial results for the first quarter ended March 30, 2024.

  May 7, 2024

   · 

  21 min read
• Business

  Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2024

  Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and the patient, announced that it plans to release 2024 first quarter financial and operating results after the market closes on Tuesday, May 14, 2024.

  May 7, 2024

   · 

  1 min read
• Business

  CMR Surgical appoints Shlomi Cohen as Chief Financial Officer

  CMR Surgical – the global surgical robotics business announces the appointment of Shlomi Cohen as Chief Financial Officer, effective immediately.

  May 7, 2024

   · 

  4 min read
• Business

  SOPHiA GENETICS Reports First Quarter 2024 Results

  SOPHiA GENETICS, a cloud-native software company and leader in data-driven medicine, reported financial results for the first quarter ended March 31, 2024.

  May 7, 2024

   · 

  21 min read
• Memo Therapeutics increases Series C financing to CHF 45 million

  Memo Therapeutics AG announces that it has successfully raised CHF 20 million as part of an extension of its Series C financing, bringing the total amount raised in the funding round to CHF 45 million.

  May 7, 2024

   · 

  5 min read
• Innate Pharma Announces Conference Call and Webcast for Q1 2024 Business Update

  Innate Pharma SA, announced that the Company will hold a conference call on Tuesday, May 14, 2024, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first quarter of 2024.

  May 7, 2024

   · 

  3 min read
• Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024

  Photocure ASA, the Bladder Cancer Company, announces its participation in the congress, and two abstract presentations at the AUA 2024: the American Urological Association Annual Congress 2024 was held May 3-6, 2024, in San Antonio, TX, USA.

  May 7, 2024

   · 

  8 min read
• Business

  Sciwind Biosciences and HK inno.N Corporation Announce Licensing and Partnership Agreement for Ecnoglutide Injection (XW003) in South Korea

  Sciwind Biosciences Co., Ltd. and HK inno.N Corporation announced a licensing and partnership agreement for the development and commercialization of ecnoglutide injection, a novel GLP-1 analog for the treatment of type 2 diabetes, obesity and MASH, in South Korea.

  May 7, 2024

   · 

  4 min read
• Business

  Atopia Therapeutics, Formerly HpVac, Announces Appointment of Dr. Gregoire Chevalier as CEO and Business Update

  Atopia Therapeutics, a leader in the development of breakthrough asthma and allergy therapies, announced the appointment of Dr. Grégoire Chevalier as Chief Executive Officer.

  May 7, 2024

   · 

  3 min read
• Deals

  Selvita completes acquisition of PozLab and significantly expands its drug development capabilities

  Selvita S.A. announced completion of a strategic transaction in which it has acquired 100% of shares in PozLab.

  May 7, 2024

   · 

  2 min read